RECURSION PHARMACEUTICALS-A (RXRX) Institutional Ownership and Insiders Activity

RECURSION PHARMACEUTICALS-A (RXRX) is widely held by institutional investors, with 330 firms reporting positions valued at approximately $1.34B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $184.62M in RXRX holdings in its latest filing.

Recent insider activity includes 10 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.